AVTE insider transaction filings
Aerovate Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-08-02. Screen AVTE transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for AVTE between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Aerovate Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-08-02 | 4 | Dake Benjamin T — SEE REMARKS | Option exercise (M): 11,454 @ $1.74 · Option exercise (M): 1,507 @ $1.74 · Option exercise (M): 906 (derivative) @ $0 · Option exercise (M): 10,548 (derivative) @ $0 · Option exercise (M): 1,507 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 928,110 @ $1.67 | EDGAR |
| 2024-06-14 | 4 | Verwijs Marinus — CHIEF TECHNICAL OFFICER | Option exercise (M): 10,600 @ $14.59 · Sale (S): 10,600 @ $25 · Option exercise (M): 10,600 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 6,000 @ $2.14 · Sale (S): 6,000 @ $24.50 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Eldridge George A — SEE REMARKS | Option exercise (M): 15,000 @ $2.14 · Sale (S): 15,000 @ $25.03 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | GRAYZEL DAVID S. — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Katabi Maha — Director, 10% owner | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Resnick Joshua — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Dable Habib J — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Dorval Allison — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Iwicki Mark T — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Santel Donald J — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 4,000 @ $2.14 · Sale (S): 3,914 @ $21.07 · Sale (S): 86 @ $21.86 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | NOYES TIMOTHY P — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 10,000 @ $2.14 · Sale (S): 8,707 @ $21.52 · Sale (S): 1,293 @ $21.92 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Verwijs Marinus — CHIEF TECHNICAL OFFICER | Sale (S): 1,981 @ $21.02 | EDGAR |
| 2024-05-03 | 4 | NOYES TIMOTHY P — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 10,000 @ $2.14 · Sale (S): 9,035 @ $20.34 · Sale (S): 965 @ $20.87 · Sale (S): 1,357 @ $19.91 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | Dake Benjamin T — SEE REMARKS | Option exercise (M): 6,853 @ $2.14 · Sale (S): 6,447 @ $22.32 · Sale (S): 338 @ $23.17 · Sale (S): 68 @ $23.97 · Option exercise (M): 6,853 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 4,000 @ $1.74 · Sale (S): 3,689 @ $22.30 · Sale (S): 311 @ $23.33 · Option exercise (M): 503 (derivative) @ $0 · Option exercise (M): 3,497 (derivative) @ $0 | EDGAR |
| 2024-04-18 | 4 | NOYES TIMOTHY P — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 10,000 @ $2.14 · Sale (S): 4,491 @ $24.40 · Sale (S): 5,509 @ $24.94 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-04-12 | 4 | Eldridge George A — SEE REMARKS | Option exercise (M): 7,500 @ $2.14 · Sale (S): 6,729 @ $26.77 · Sale (S): 771 @ $27.56 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2024-04-11 | 4 | GRAYZEL DAVID S. — Director | Sale (S): 11,882 @ $28.15 | EDGAR |
| 2024-04-03 | 4 | Verwijs Marinus — CHIEF TECHNICAL OFFICER | Option exercise (M): 5,300 @ $14.59 · Sale (S): 3,796 @ $28.87 · Sale (S): 1,504 @ $30.00 · Option exercise (M): 5,300 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Dake Benjamin T — SEE REMARKS | Option exercise (M): 3,325 @ $10.61 · Sale (S): 3,325 @ $31.97 · Option exercise (M): 3,325 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Eldridge George A — SEE REMARKS | Option exercise (M): 12,495 @ $2.14 · Sale (S): 12,495 @ $31.23 · Option exercise (M): 12,495 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | NOYES TIMOTHY P — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 10,000 @ $2.14 · Sale (S): 4,502 @ $28.96 · Sale (S): 1,647 @ $29.90 · Sale (S): 2,851 @ $31.02 · Sale (S): 1,000 @ $31.95 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 9,000 @ $2.14 · Sale (S): 9,000 @ $29.50 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2024-03-28 | 4 | Dake Benjamin T — SEE REMARKS | Option exercise (M): 11,068 @ $10.61 · Sale (S): 11,068 @ $27.97 · Option exercise (M): 11,068 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Dake Benjamin T — SEE REMARKS | Option exercise (M): 3,432 @ $10.61 · Sale (S): 3,432 @ $28.01 · Option exercise (M): 3,432 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Verwijs Marinus — CHIEF TECHNICAL OFFICER | Option exercise (M): 5,300 @ $14.59 · Sale (S): 2,536 @ $25.68 · Sale (S): 2,764 @ $26.46 · Option exercise (M): 5,300 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 4,000 @ $1.74 · Option exercise (M): 3,000 @ $2.14 · Sale (S): 6,387 @ $25.81 · Sale (S): 613 @ $26.40 · Option exercise (M): 4,000 (derivative) @ $0 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Dake Benjamin T — SEE REMARKS | Option exercise (M): 20,557 @ $2.14 · Option exercise (M): 14,500 @ $10.61 · Sale (S): 27,476 @ $25.74 · Sale (S): 7,581 @ $26.48 · Option exercise (M): 20,557 (derivative) @ $0 · Option exercise (M): 14,500 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | Eldridge George A — SEE REMARKS | Option exercise (M): 2,051 @ $2.14 · Sale (S): 2,051 @ $25.05 · Option exercise (M): 2,016 @ $2.14 · Sale (S): 2,016 @ $25.02 · Option exercise (M): 2,051 (derivative) @ $0 · Option exercise (M): 2,016 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 8,975 @ $2.14 · Sale (S): 8,975 @ $24.50 · Option exercise (M): 945 (derivative) @ $0 · Option exercise (M): 8,030 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Eldridge George A — SEE REMARKS | Option exercise (M): 22,386 @ $2.14 · Sale (S): 22,386 @ $25.00 · Option exercise (M): 114 @ $2.14 · Sale (S): 114 @ $25 · Option exercise (M): 3,433 @ $2.14 · Sale (S): 3,423 @ $25.24 · +5 more | EDGAR |
| 2024-03-06 | 4 | Dable Habib J — Director | Grant/award (A): 1,531 (derivative) @ $16.37 | EDGAR |
| 2024-02-27 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 511 @ $1.74 · Sale (S): 511 @ $19.50 · Option exercise (M): 511 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 3,489 @ $1.74 · Sale (S): 2,591 @ $20.11 · Sale (S): 898 @ $20.58 · Option exercise (M): 2,502 (derivative) @ $0 · Option exercise (M): 987 (derivative) @ $0 | EDGAR |
| 2024-02-07 | 4 | NIVEN RALPH — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 1,400 @ $1.74 · Option exercise (M): 3,200 @ $2.14 · Sale (S): 4,600 @ $17.45 · Option exercise (M): 900 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0 · +2 more | EDGAR |
| 2024-01-31 | 4 | NOYES TIMOTHY P — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Pigot Timothy — CHIEF COMMERCIAL OFFICER | Grant/award (A): 66,586 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Verwijs Marinus — CHIEF TECHNOLOGY OFFICER | Grant/award (A): 66,586 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Grant/award (A): 66,586 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Dake Benjamin T — SEE REMARKS | Grant/award (A): 66,586 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Eldridge George A — SEE REMARKS | Grant/award (A): 66,586 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | NIVEN RALPH — CHIEF SCIENTIFIC OFFICER | Grant/award (A): 66,586 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 4,000 @ $1.74 · Sale (S): 4,000 @ $19.50 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-01-08 | 4 | NIVEN RALPH — CHIEF SCIENTIFIC OFFICER | Option exercise (M): 1,400 @ $1.74 · Option exercise (M): 3,200 @ $2.14 · Sale (S): 2,126 @ $18.67 · Sale (S): 2,474 @ $19.57 · Option exercise (M): 900 (derivative) @ $0 · Option exercise (M): 500 (derivative) @ $0 · +3 more | EDGAR |
| 2024-01-04 | 4 | Dable Habib J — Director | Grant/award (A): 2,964 (derivative) @ $13.49 | EDGAR |
| 2024-01-04 | 4 | Santel Donald J — Director | Grant/award (A): 2,889 (derivative) @ $13.49 | EDGAR |
Recent 8-K events — Aerovate Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-06-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AVTE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →